cancer AI
The AI, integrated into a hand-held point-of-care device, demonstrated 94% diagnostic accuracy.
Lunit and Coreline Soft have been tapped to join large-scale cancer screening programs.
Claimed to be a world's first, the LLM-driven model has demonstrated over 90% accuracy.